Clinical trial
Celecoxib and Radiation Therapy in Treating Patients With Stage II or Stage III…
NCT00450736 · University of Miami, Other · Completed
Key facts
| NCT number | NCT00450736 |
|---|---|
| Title | Celecoxib and Radiation Therapy in Treating Patients With Stage II or Stage III Soft Tissue Sarcoma of the Arm, Hand, Leg, or Foot That Has Been Removed by Surgery |
| Official title | A Phase I Trial of Postoperative Radiation With Dose-Escalation of A Cox-2 Inhibitor, Celebrex™ (CELECOXIB) in Patients With Soft Tissue Sarcoma of the Extremity |
| Lead sponsor | University of Miami, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Childhood Malignant Fibrous Histiocytoma of Bone, Sarcoma |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | celecoxib, adjuvant therapy, radiation therapy |
| Enrollment | 3 |
| Start date | Mar 1, 2004 |
| Primary completion | May 1, 2009 |
| Completion | May 1, 2009 |
| First posted | Mar 22, 2007 |
| Last update posted | Dec 15, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: